HBM Holdings Limited (HKG:2142)
Hong Kong
· Delayed Price · Currency is HKD 14.20
+0.46 (3.35%)
At close: Dec 5, 2025
HBM Holdings Revenue
HBM Holdings had revenue of $101.32M USD in the half year ending June 30, 2025, with 147.13% growth. This brings the company's revenue in the last twelve months to $115.71M, up 60.25% year-over-year. In the year 2024, HBM Holdings had annual revenue of $38.10M, down -57.43%.
Revenue (ttm)
$115.71M
Revenue Growth
+60.25%
P/S Ratio
13.59
Revenue / Employee
$632.32K
Employees
183
Market Cap
12.35B HKD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 38.69B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| JD Health International | 71.34B |
| Innovent Biologics | 12.52B |
| WuXi Biologics | 21.98B |
| Sino Biopharmaceutical | 33.49B |
| Akeso | 2.75B |
| Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |